Lamond Capital Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-15,390
Closed -$1.43M 21
2014
Q4
$1.43M Buy
+15,390
New +$1.43M 0.94% 15